Evidence map›Paper›PMID 26038227›Full record

ReviewCurrent opinion in structural biology2015

Recent advances in engineering microbial rhodopsins for optogenetics.

R Scott McIsaac, Claire N Bedbrook, Frances H Arnold

Abstract readReview
In one paragraph

Review in Current opinion in structural biology, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 25 papers.

0numbers the graph read from it
0cells of the map it votes in
25citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

25 citing papers in PubMed.

  1. Article
  2. Article
  3. Sensing a rainbow of colors: algal photoreceptors.Frontiers in plant science · 2025
    Review
  4. Review
  5. Review
  6. Article
  7. Article
  8. Review
  9. Article
  10. Modified Rhodopsins FromFrontiers in molecular biosciences · 2021
    Article
  11. Toward Multiplexed Optogenetic Circuits.Frontiers in bioengineering and biotechnology · 2021
    Review
  12. Article
  13. Article
  14. Article
  15. Article
  16. Light-Controlled Mammalian Cells and Their Therapeutic Applications in Synthetic Biology.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2019
    Review
  17. Article
  18. Review
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

R Scott McIsaac *Division of Chemistry and Chemical Engineering, Mail Code 210-41, California Institute of Technology, Pasadena, California, United States of America.
Claire N Bedbrook *Division of Biology and Biological Engineering, Mail Code 156-29, California Institute of Technology, Pasadena, California, United States of America.
Frances H ArnoldDivision of Chemistry and Chemical Engineering, Mail Code 210-41, California Institute of Technology, Pasadena, California, United States of America.

Funding

Engineering Microbial Opsins for Neuroscience via Structure-Guided RecombinationR21MH103824 · NIMH · CALIFORNIA INSTITUTE OF TECHNOLOGY · PI ARNOLD, FRANCES H, GRADINARU, VIVIANA · 2014 to 2015
$458k
Opsineering: Engineering Novel ChannelRhodospins for Optogenetics ApplicationsF31MH102913 · NIMH · CALIFORNIA INSTITUTE OF TECHNOLOGY · PI BEDBROOK, CLAIRE NICOLE · 2014 to 2016
$110k
NIMH NIH HHS 1R21MH103824-01NIMH NIH HHS F31 MH102913NIMH NIH HHS R21 MH103824
6 · The paper itself

Abstract

Protein engineering of microbial rhodopsins has been successful in generating variants with improved properties for applications in optogenetics. Members of this membrane protein family can act as both actuators and sensors of neuronal activity. Chimeragenesis, structure-guided mutagenesis, and directed evolution have proven effective strategies for tuning absorption wavelength, altering ion specificity and increasing fluorescence. These approaches facilitate the development of useful optogenetic tools and, in some cases, have yielded insights into rhodopsin structure-function relationships.

Indexed as

Protein EngineeringAnimalsBiosensing TechniquesElectrophysiologyMammalsNeuronsOptogeneticsProtein ConformationRhodopsins, MicrobialRhodopsins, Microbial

Identifiers

PMID26038227
PMCPMC4641784

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.